Sign inJoin waitlistJoin the waitlist

Bradley Leibovich

Chair Department of Urology · Duke University Hospital

Credentials: · · ·

History

Urology Department · Duke University Hospital
Present
Mayo Clinic College of Medicine and Science
Present

Urologic Oncology Indiana University Medical Center
2007–2008
Urology
Mayo Clinic College of Medicine and Science
2002–2007
General Surgery
Mayo Clinic College of Medicine and Science
1995–2002
Albany Medical College
1991–1995

Research

Renal Mass and Localized Renal Cancer: AUA Guideline
The Journal of Urology · 2017 · 979 citations
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up
Cancer Research · 2006 · 723 citations
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
Proceedings of the National Academy of Sciences of the United States of America · 2004 · 664 citations

John Cheville
197 papers · 8 as a resident
RT
Robert Thompson
194 papers · 35 as a resident
Stephen Boorjian
171 papers · 42 as a resident
Michael Blute
113 papers
HZ
Horst Zincke
59 papers
Brian Costello
55 papers
Eugene Kwon
53 papers
Vidit Sharma
39 papers · 7 as a resident
Igor Frank
37 papers · 23 as a resident
Sounak Gupta
32 papers · 4 as a fellow
Thomas Atwell
30 papers
Rafael Jimenez
26 papers

Grants

Intravesical Oncolytic Therapy for Bladder Cancer
National Cancer Institute · R44
PI · $1.1M · Vyriad, Inc.
2017–2020

Clinical trials

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2003–2006
Exisulind Versus Placebo After Surgical Removal of the Prostate
Principal investigator · Completed · Phase 2
Mayo Clinic
2003–2008
Exisulind Prior to Radical Prostatectomy
Principal investigator · Completed · Phase 2
Mayo Clinic
2002–2007